These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24699040)

  • 1. Oral SAMe in persistent treatment-refractory bipolar depression: a double-blind, randomized clinical trial.
    Murphy BL; Babb SM; Ravichandran C; Cohen BM
    J Clin Psychopharmacol; 2014 Jun; 34(3):413-6. PubMed ID: 24699040
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of the antidepressive action of sulfoadenosyl-L-methionine compared with that of chlorimipramine].
    Giner Ubago J; González Infante JM; Blanco Picabia A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):73-80. PubMed ID: 6372376
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.
    Kagan BL; Sultzer DL; Rosenlicht N; Gerner RH
    Am J Psychiatry; 1990 May; 147(5):591-5. PubMed ID: 2183633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch and S-adenosylmethionine.
    Carney MW; Chary TK; Bottiglieri T; Reynolds EH
    Ala J Med Sci; 1988 Jul; 25(3):316-9. PubMed ID: 3052141
    [No Abstract]   [Full Text] [Related]  

  • 5. SAMe for depression.
    Med Lett Drugs Ther; 1999 Nov; 41(1065):107-8. PubMed ID: 10575417
    [No Abstract]   [Full Text] [Related]  

  • 6. SAMe (S-adenosylmethionine).
    Echols JC; Naidoo U; Salzman C
    Harv Rev Psychiatry; 2000; 8(2):84-90. PubMed ID: 10902097
    [No Abstract]   [Full Text] [Related]  

  • 7. Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial.
    Saricicek A; Maloney K; Muralidharan A; Ruf B; Blumberg HP; Sanacora G; Lorberg B; Pittman B; Bhagwagar Z
    J Clin Psychiatry; 2011 Jun; 72(6):744-50. PubMed ID: 21034692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy in response and remission rates for SAMe-treated patients in a double-blind, randomized clinical trial.
    Fleisch SB; Travis MJ; Ryan ND
    Am J Psychiatry; 2010 Dec; 167(12):1533; author reply 1533. PubMed ID: 21131413
    [No Abstract]   [Full Text] [Related]  

  • 9. [Controlled double-blind study (SAMe-imipramine) in depressive syndromes].
    Mantero M; Pastorino P; Carolei A; Agnoli A
    Minerva Med; 1975 Nov; 66(78):4098-101. PubMed ID: 1103017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the antidepressant activity and of S-adenosylmethionine (SAMe) and that of some tricyclic drugs.
    Miccoli L; Porro V; Bertolino A
    Acta Neurol (Napoli); 1978; 33(3):243-55. PubMed ID: 371351
    [No Abstract]   [Full Text] [Related]  

  • 11. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
    Berk M; Copolov DL; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Bush AI
    Biol Psychiatry; 2008 Sep; 64(6):468-75. PubMed ID: 18534556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar depression: a randomized, double-blind, placebo-controlled study.
    Stamm TJ; Lewitzka U; Sauer C; Pilhatsch M; Smolka MN; Koeberle U; Adli M; Ricken R; Scherk H; Frye MA; Juckel G; Assion HJ; Gitlin M; Whybrow PC; Bauer M
    J Clin Psychiatry; 2014 Feb; 75(2):162-8. PubMed ID: 24345793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
    J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine: a depression mood stabiliser.
    Herman E
    Eur Neuropsychopharmacol; 2004 May; 14 Suppl 2():S89-93. PubMed ID: 15142613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 17. Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder.
    Weiser M; Burshtein S; Gershon AA; Marian G; Vlad N; Grecu IG; Tocari E; Tiugan A; Hotineanu M; Davis JM
    Bipolar Disord; 2014 Jun; 16(4):441-7. PubMed ID: 24712840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical trial of dimethacrine].
    Melo I
    Rev Med Suisse Romande; 1971 Mar; 91(3):183-94. PubMed ID: 5092364
    [No Abstract]   [Full Text] [Related]  

  • 19. Inositol augmentation of lithium or valproate for bipolar depression.
    Eden Evins A; Demopulos C; Yovel I; Culhane M; Ogutha J; Grandin LD; Nierenberg AA; Sachs GS
    Bipolar Disord; 2006 Apr; 8(2):168-74. PubMed ID: 16542187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant activity of S-adenosylmethionine.
    Caruso I; Fumagalli M; Boccassini L; Sarzi Puttini P; Ciniselli G; Cavallari G
    Lancet; 1984 Apr; 1(8382):904. PubMed ID: 6143204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.